- Report
- June 2025
- 150 Pages
Global
From €2481EUR$2,699USD£2,115GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2564EUR$2,789USD£2,185GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2564EUR$2,789USD£2,185GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2564EUR$2,789USD£2,185GBP
- Report
- June 2025
- 400 Pages
Global
From €4549EUR$4,949USD£3,877GBP
- Report
- May 2025
- 300 Pages
Global
From €4549EUR$4,949USD£3,877GBP
- Report
- January 2025
- 250 Pages
Global
From €4595EUR$4,999USD£3,917GBP
- Report
- August 2024
- 150 Pages
Global
From €2564EUR$2,789USD£2,185GBP
- Report
- June 2023
- 120 Pages
Asia Pacific
From €3557EUR$3,869USD£3,031GBP
- Report
- May 2023
- 160 Pages
Global
From €4549EUR$4,949USD£3,877GBP
- Report
- May 2023
- 147 Pages
Global
From €4549EUR$4,949USD£3,877GBP
- Report
- March 2023
- 147 Pages
Global
From €4549EUR$4,949USD£3,877GBP
- Report
- March 2023
- 147 Pages
Global
From €4549EUR$4,949USD£3,877GBP
- Report
- May 2023
- 116 Pages
Global
From €4137EUR$4,500USD£3,526GBP
- Report
- July 2024
- 139 Pages
Global
From €2298EUR$2,500USD£1,959GBP
- Report
- December 2023
- 142 Pages
Brazil
From €2298EUR$2,500USD£1,959GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1149EUR$1,250USD£979GBP
- Drug Pipelines
- July 2024
- 100 Pages
Global
From €3447EUR$3,750USD£2,938GBP
- Report
- June 2026
- 138 Pages
United Kingdom
From €3676EUR$3,999USD£3,133GBP
- Report
- April 2026
- 148 Pages
Germany
From €3676EUR$3,999USD£3,133GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more